MuReva Phototherapy Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Angel
- Investors
-
8
MuReva Phototherapy General Information
Description
Developer of medical therapeutic devices designed to treat oral mucositis. The company's technology utilizes photobiomodulation by emitting lasers to treat the damage caused by cancer-killing therapies, helping reduce mucosal injury in patients undergoing radiation and chemotherapy for various cancers and also eliminate mouth ulcers, the most common, debilitating and costly side effect of cancer therapy, enabling patients to have a technology that can treat and potentially prevent this terrible side effect
Contact Information
Website
murevapt.comCorporate Office
- 6611 West Snowville Road
- Brecksville, OH 44141
- United States
Corporate Office
- 6611 West Snowville Road
- Brecksville, OH 44141
- United States
MuReva Phototherapy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Angel (individual) | 01-Jan-2025 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC (Series A) | 01-Oct-2023 | Completed | Clinical Trials - General | |||
| 6. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 5. Early Stage VC | 01-Jan-2021 | Completed | Clinical Trials - General | |||
| 4. Accelerator/Incubator | 24-Jan-2020 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 12-Dec-2018 | Completed | Clinical Trials - General | |||
| 2. Grant | 13-Sep-2018 | $1.7M | Completed | Clinical Trials - General | ||
| 1. Spin-Off | 01-Jan-2018 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MuReva Phototherapy Patents
MuReva Phototherapy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024297981-A1 | Intraoral phototherapy probe | Pending | 26-Jul-2023 | ||
| EP-4750527-A1 | Intraoral phototherapy probe | Pending | 26-Jul-2023 | ||
| US-20250032816-A1 | Intraoral phototherapy probe | Pending | 26-Jul-2023 | ||
| WO-2025024371-A1 | Intraoral phototherapy probe | Inactive | 26-Jul-2023 | ||
| AU-2022341121-A1 | Intraoral phototherapy device | Active | 09-Sep-2021 | A61N5/0613 |
MuReva Phototherapy Signals
MuReva Phototherapy Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Band of Angels | Angel Group | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| Jumpstart Ventures | Venture Capital | Minority | ||
| M7 Ace Neo | Venture Capital | Minority | ||
| Angel Physicians Fund | Angel Group | Minority |
MuReva Phototherapy FAQs
-
When was MuReva Phototherapy founded?
MuReva Phototherapy was founded in 2018.
-
Where is MuReva Phototherapy headquartered?
MuReva Phototherapy is headquartered in Brecksville, OH.
-
What is the size of MuReva Phototherapy?
MuReva Phototherapy has 10 total employees.
-
What industry is MuReva Phototherapy in?
MuReva Phototherapy’s primary industry is Other Devices and Supplies.
-
Is MuReva Phototherapy a private or public company?
MuReva Phototherapy is a Private company.
-
What is MuReva Phototherapy’s current revenue?
The current revenue for MuReva Phototherapy is .
-
How much funding has MuReva Phototherapy raised over time?
MuReva Phototherapy has raised $1.28M.
-
Who are MuReva Phototherapy’s investors?
Band of Angels, Keiretsu Forum, Jumpstart Ventures, M7 Ace Neo, and Angel Physicians Fund are 5 of 8 investors who have invested in MuReva Phototherapy.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process